Anticipating PTSD in severe COVID survivors: the case for screen-and-treat. Issue 1 (31st December 2022)

• Record Type: Journal Article
• Authors: Greene, Talya; El-Leithy, Sharif; Billings, Jo; Albert, Idit; Birch, Jennifer; Campbell, Mari; Ehntholt, Kim; Fortune, Lorna; Gilbert, Nicola; Grey, Nick; Hana, Laurinne; Kennerley, Helen; Lee, Deborah; Lunn, Sarah; Murphy, Dominic; Robertson, Mary; Wade, Dorothy; Brewin, Chris R.; Bloomfield, Michael A. P.
• Is Part Of: European journal of psychotraumatology. Volume 13:Issue 1(2022)
• Publication Date: 2022-12-31
• Subjects: Psychological trauma -- mental health screening -- PTSD assessment -- long COVID -- intensive care -- critical care; Trauma Psicológico -- Detección en Salud Mental -- Evaluación de TEPT -- COVID Largo -- Cuidados Intensivos -- Cuidado Crítico; 心理创伤 -- 心理健康筛查 -- PTSD评估 -- 长期COVID -- 重症监护 -- 危重护理; Post-traumatic stress disorder -- Periodicals; Stress Disorders, Post-Traumatic; Post-traumatic stress disorder; Electronic journals; Periodicals; Periodicals; Fulltext; Internet Resources; Periodicals; 616.8521
• DOI: 10.1080/20008198.2021.1959707
• Languages: English
• ISSNs: 2000-8198

Abstract

ABSTRACT: Based on research from previous pandemics, studies of critical care survivors, and emerging COVID-19 data, we estimate that up to 30% of survivors of severe COVID will develop PTSD. PTSD is frequently undetected across primary and secondary care settings and the psychological needs of survivors may be overshadowed by a focus on physical recovery. Delayed PTSD diagnosis is associated with poor outcomes. There is a clear case for survivors of severe COVID to be systematically screened for PTSD, and those that develop PTSD should receive timely access to evidence-based treatment for PTSD and other mental health problems by multidisciplinary teams. HIGHLIGHTS: We anticipate that up to 30% of survivors of severe COVID will develop PTSD, yet PTSD is frequently undetected in primary and secondary care settings. There is, therefore, a clear case for establishing systematic screening and ensuring timely access to treatment.